1-5 of 5
Megan Helena Jagosky, MD
Close
Sort by
Journal Articles

Natural History of Patients with Multiple Myeloma Refractory to CD38-Targeted Monoclonal Antibody-Based Treatment

Ujjawal H Gandhi, PhD MBBS, Arjun Lakshman, MD MRCP, Zhubin Gahvari, MD, Elizabeth McGehee, MD, Megan Helena Jagosky, MD, Ridhi Gupta, MBBS, William Varnado, MD, Saurabh Chhabra, MD, Mark A. Fiala, BS, Ehsan Malek, MD, Joshua Mansour, MD, Barry Paul, MD, Alyssa Barnstead, Saranya Kodali, MD, Amarendra K. Neppalli, MD, Michaela Liedtke, MD, Kelly N. Godby, MD, Yubin Kang, MD, Ankit Kansagra, MD, Emma C. Scott, MD, Elvira Umyarova, MD, Parameswaran Hari, MBBS, MD, Ravi Vij, MBBS, Saad Z. Usmani, MD, Natalie Scott Callander, MD, Robert Frank Cornell, MD, Shaji K. Kumar, MD, Luciano J Costa, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3233.
https://doi.org/10.1182/blood-2018-99-111033
Published: 2018
Journal Articles

Natural History of Patients with Multiple Myeloma Refractory to Elotuzumab and Outcomes of Subsequent Therapy with Anti-CD38 Monoclonal Antibodies

William Varnado, MD, Megan Helena Jagosky, MD, Zhubin Gahvari, MD, Saurabh Chhabra, MD, Ujjawal H Gandhi, PhD MBBS, Arjun Lakshman, MD MRCP, Elizabeth McGehee, MD, Ridhi Gupta, MBBS, Ehsan Malek, MD, Mark A. Fiala, BS, Joshua Mansour, MD, Barry Paul, MD, Alyssa Barnstead, Saranya Kodali, MD, Neppalli Amarendra, MD, Michaela Liedtke, MD, Kelly N. Godby, MD, Yubin Kang, MD, Ankit Kansgra, MD, Emma C. Scott, MD, Elvira Umyarova, MD, Parameswaran Hari, MBBS, MD, Ravi Vij, Saad Z. Usmani, MD, Robert Frank Cornell, MD, Shaji K. Kumar, MD, Natalie Scott Callander, MD, Luciano J Costa, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3303.
https://doi.org/10.1182/blood-2018-99-112246
Published: 2018
Journal Articles

Risk Factors for Thromboembolism (TE) in Multiple Myeloma (MM) Patients (pts) Treated with Immunomodulatory Agents (IMiDs) Plus Dexamethasone (dex)

Jai N Patel, PharmD, BCOP, Megan Helena Jagosky, MD, Myra M Robinson, MSPH, Daniel Slaughter, Justin Arnall, PharmD, CPP, BCOP, Ashley Matusz-Fisher, MD, Manisha Bhutani, MD, Peter M. Voorhees, MD, Saad Z. Usmani, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4814.
https://doi.org/10.1182/blood-2018-99-118283
Published: 2018
Journal Articles

Rapid Infusion Daratumumab Is Safe and Well Tolerated in Clinical Practice

Issam S. Hamadeh, PharmD, Justin Arnall, Pharm.D., Ekaterina Kachur, PharmD, Allison Martin, PharmD, Megan Helena Jagosky, MD, Reed Friend, MD, Shebli Atrash, Manisha Bhutani, MD, Peter M. Voorhees, MD, Saad Z. Usmani, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2255.
https://doi.org/10.1182/blood-2018-99-118737
Published: 2018
Journal Articles

Subsequent Treatment Outcomes of Multiple Myeloma Refractory to CD38-Monoclonal Antibody Therapy

Robert Frank Cornell, MD, Ujjawal H Gandhi, PhDMBBS, Arjun Lakshman, MD MRCP, Zhubin Gahvari, MD, Megan Helena Jagosky, MD, Elizabeth McGehee, MD, William Varnado, MD, Ridhi Gupta, MD, Saurabh Chhabra, MD, Mark A. Fiala, BS, Ehsan Malek, MD, Joshua Mansour, MD, Barry Paul, MD, Alyssa Barnstead, Saranya Kodali, MD, Amarendra K. Neppalli, MD, Michaela Liedtke, MD, Kelly N. Godby, MD, Yubin Kang, MD, Ankit Kansagra, MD, Elvira Umyarova, MD, Emma C. Scott, MD, Parameswaran Hari, MBBS, MD, Ravi Vij, MBBS, Saad Z. Usmani, MD, Natalie Scott Callander, MD, Luciano J Costa, MD PhD, Shaji K. Kumar, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2015.
https://doi.org/10.1182/blood-2018-99-115078
Published: 2018